Choueiri, T. K., Motzer, R. J., Karam, J. A., Yip, W., Suarez, C., Ye, D., He, Z., Caglevic, C., Ferguson, T., Chang, Y., Rojas, C., Iacovelli, R., Ürün, Y., Verzoni, E., Limón, J. C. V., Porta, C., Uzzo, R. G., Lee, J. L., Venugopal, B., McKay, R. R., Hammers, H., Miyake, H., Chahoud, J., Liu, H., Burgents, J. E., Sharma, M., Powles, T. B. (2026). Adjuvant Pembrolizumab plus Belzutifan for Renal-Cell Carcinoma. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2518245